Advertisement
News
Advertisement

Metamark Genetics appoints Blume-Jensen as CSO

Fri, 09/17/2010 - 9:38am
Mass High Tech: The Journal of New England Technology

Molecular diagnostics firm Metamark Genetics Inc. has named Peter Blume-Jensen as chief scientific officer of the company.

With a history in personalized oncology medicine, Blume-Jensen has worked most recently as executive director of external scientific affairs and vice president at the Daiichi Sankyo Research Institute of Daiichi Sankyo Inc. He previously served as department head at EMD Serono Inc., as well as at Merck Research Laboratories, Merck & Co., the parent company of EMD Serono.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading